Zhitong Finance App News, Liankang Biotechnology Group (00690.HK) issued an announcement. Recently, in Wenzhou City, Zhejiang Province, the group formally signed a tripartite strategic cooperation agreement with the Wenzhou Medical University National Engineering Research Center for Cell Growth Factor Drugs and Protein Preparations (Wenzhou Medical University National Engineering Research Center) and the Wenzhou Ouhai District People's Government to discuss the subsequent joint construction of the “Liankang-Wenzhou Medical University Translational Medicine Joint Innovation Laboratory” (Joint Laboratory). This collaboration will help strengthen the Group's R&D pipeline layout in the fields of dermatology, ophthalmology and metabolism-related diseases, and accelerate the strategy implementation process.

Zhitongcaijing · 12/30/2025 09:01
Zhitong Finance App News, Liankang Biotechnology Group (00690.HK) issued an announcement. Recently, in Wenzhou City, Zhejiang Province, the group formally signed a tripartite strategic cooperation agreement with the Wenzhou Medical University National Engineering Research Center for Cell Growth Factor Drugs and Protein Preparations (Wenzhou Medical University National Engineering Research Center) and the Wenzhou Ouhai District People's Government to discuss the subsequent joint construction of the “Liankang-Wenzhou Medical University Translational Medicine Joint Innovation Laboratory” (Joint Laboratory). This collaboration will help strengthen the Group's R&D pipeline layout in the fields of dermatology, ophthalmology and metabolism-related diseases, and accelerate the strategy implementation process.